MYX 0.28% $7.24 mayne pharma group limited

From my observation of the last 3-4 years The CEO bought Revenue...

  1. 1,314 Posts.
    lightbulb Created with Sketch. 261
    From my observation of the last 3-4 years
    The CEO bought Revenue Increase.
    Paying Teva Top $. Capital Raising and
    Debt. This obviously increased Revenue.
    So now Company has valuation $3billion+.
    CEO now deserves huge Salary increases
    and also his Senior Executives accordingly.
    Since then for past 3 years Company has consistently failed to deliver. Shareholders
    particularly LT ones remained loyal and have
    paid the price. CEO and his Yes Men fellow
    cohorts not suffered at all as far as I can see.
    I wish to see some of the Pain Shared and
    said CEO be financially rewarded relative to
    current share price. Otherwise leave and allow
    a Competant Individual to replace you.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.24
Change
0.020(0.28%)
Mkt cap ! $615.9M
Open High Low Value Volume
$7.30 $7.32 $7.10 $1.066M 147.5K

Buyers (Bids)

No. Vol. Price($)
1 169 $7.17
 

Sellers (Offers)

Price($) Vol. No.
$7.24 3916 2
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
$7.23
  Change
0.020 ( 0.47 %)
Open High Low Volume
$7.23 $7.33 $7.11 37253
Last updated 15.59pm 28/03/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.